Lung Cancer Drugs

FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation

Lumakras (sotorasib)
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific [...]

Topotecan–Berzosertib Combination Effective for SCLC Treatment

Skeletal Model of Topotecan
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of [...]

FDA Approves Libtayo as Monotherapy for Advanced NSCLC

Libtayo | Lung Cancer
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]

New Study Identifies Drug to Boost Lung Cancer Survival Rates

Lung Cancer
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]

Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk

Drug
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]

NICE now recommends AstraZeneca’s Tagrisso for Lung Cancer Treatment

lung | Lung Cancer
The National Institute of Health and Care Excellence (NICE) has announced the recommendation of Tagrisso (osimertinib) for routine use in two new lung cancer [...]

FDA Approves Gavreto for Metastatic Non-Small Cell Lung Cancer

FDA Approved | Lung Cancer
The Food and Drug Administration (FDA) has approved Gavreto (pralsetinib) for treatment of patients with metastatic non-small cell lung cancer (NSCLC). [...]

Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]

FDA Approves Tabrecta, First Targeted Therapy for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]

Nintedanib for Treatment of Advanced Lung Cancer

Nintedanib | Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. [...]

Pairing Lung and Breast Cancer Drugs More Effective in Killing Cancer Cells

Drugs | Lung Cancer
According to the new study, if the drugs used to treat breast and lung cancer are combined, they overcome resistance to treatment. The study is published in [...]

Is Lung Cancer Curable?

Is Lung Cancer Curable?
Can lung cancer be cured? Is lung cancer curable if detected early? Is lung cancer treatable at any stage? Can surgery or chemotherapy cure it? These are some [...]

Tecentriq Plus Chemotherapy Approved for Small Cell Lung Cancer

Tecentriq Plus Chemotherapy Approved for Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Tecentriq, in combination with carboplatin and etoposide for the first-line treatment of patients suffering [...]

Research: Scientists Discover New Drug Target for Lung Cancer

Doctor
A group of researchers at the University of Cambridge have identified lung squamous cell carcinoma (LUSC) cells containing high amounts of protein called [...]

Drug: Nivolumab to Treat NSCLC

Formula of Nivolumab
About Nivolumab Nivolumab or Opdivo is a prescription drug used for the treatment of advanced non-small cell lung cancer. It is given to those patients where [...]

Drug: Paclitaxel to Treat NSCLC

Paclitaxel (Taxol)
In the past two decades, little progress has been made in the field of lung cancer treatment. Patients with advanced level of cancer find it difficult to [...]